MiR-337-3p Suppresses Proliferation of Epithelial Ovarian Cancer by Targeting PIK3CA and PIK3CB

Zhen Zhang,Luoyan Zhang,Bin Wang,Ran Wei,Yunxia Wang,Jipeng Wan,Chi Zhang,Lin Zhao,Xiaoxiao Zhu,Yunhong Zhang,Chu,Qiang Guo,Xunqiang Yin,Xia Li

DOI: https://doi.org/10.1016/j.canlet.2019.10.021

IF: 9.756

2019-01-01

Cancer Letters

Abstract:Epithelial ovarian cancer (EOC) is responsible for nearly 140,000 deaths worldwide each year. MicroRNAs play critical roles in cancer development and progression. The function of microRNA miR-337–3p has been described in various cancers. However, the biological role of miR-337–3p and its molecular mechanisms underlying EOC initiation and progression have not been reported. Here, we reported that the expression of miR-337–3p is down-regulated in EOC tissues and low expression of miR-337–3p is correlated with advanced pathological grade for patients. Ectopic expression of miR-337–3p inhibited proliferation and induced apoptosis and cell cycle arrest in G0/G1 phase of EOC cells. PIK3CA and PIK3CB were revealed to be direct targets of miR-337–3p for reducing the activation of PI3K/AKT signaling pathway. PIK3CA and PIK3CB were discovered to affect cell proliferation of EOC cells in combination, and only when overexpressed simultaneously in miR-337-3p-expressing cells, could fully restore cell proliferation. In vivo investigation confirmed that miR-337–3p is a tumor suppressor that control expression of PIK3CA and PIK3CB encoded protein: p110α and p110β. Altogether, our results demonstrate that miR-337–3p is a tumor suppressor in EOC that inhibits the expression of PIK3CA and PIK3CB.